PRC
BLUE

Pearl River Capital’s bluebird bio BLUE Stock Holding History

Pearl River Capital’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-330
Closed -$231K – 374
2020
Q3 		$231K Buy
+330
New +$257K 0.1% 314
2019
Q2 		– Sell
-6
Closed -$12K – 286
2019
Q1 		$12K Buy
+6
New +$10.6K 0.03% 303

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Pearl River Capital's BLUE Position: Q4 2020 in Review

Pearl River Capital sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 330 shares — an estimated $231K sold.

Pearl River Capital first reported a position in BLUE in Q1 2019 and held it in 2 quarters. The position peaked at $231K in Q3 2020. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • Pearl River Capital reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
  • Pearl River Capital sold 330 bluebird bio shares in Q4 2020, an estimated $231K.
  • Pearl River Capital first reported a position in bluebird bio in Q1 2019 and held it in 2 quarters.
  • Pearl River Capital's bluebird bio position peaked at $231K in Q3 2020.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on Pearl River Capital's 13F filing for Q4 2020, filed 12 Feb 2021.